TNFAIP8 promotes the proliferation and cisplatin chemoresistance of non-small cell lung cancer through MDM2/p53 pathway

被引:0
|
作者
Ying Xing
Yuechao Liu
Tianbo Liu
Qingwei Meng
Hailing Lu
Wei Liu
Jing Hu
Chunhong Li
Mengru Cao
Shi Yan
Jian Huang
Ting Wang
Li Cai
机构
[1] Harbin Medical University Cancer Hospital,The Fourth Department of Medical Oncology
[2] Harbin Medical University Cancer Hospital,Department of Gynecology
[3] Harbin Medical University,The Sixth Department of Medical Oncology
[4] Harbin Medical University Cancer Hospital,undefined
来源
Cell Communication and Signaling | / 16卷
关键词
TNFAIP8; NSCLC; Proliferation; Cisplatin chemoresistance; MDM2/p53 pathway;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] SIRT3 deacetylates and promotes degradation of P53 in PTEN-defective non-small cell lung cancer
    Xiong, Yanlu
    Wang, Lei
    Wang, Shan
    Wang, Mingxing
    Zhao, Jinbo
    Zhang, Zhipei
    Li, Xiaofei
    Jia, Lintao
    Han, Yong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (02) : 189 - 198
  • [32] GPRC5a suppresses the proliferation of non-small cell lung cancer under wild type p53 background
    Er, Jin
    Chao, Li
    Li, Yiwei
    Feng, Xing
    Fei, Zhao
    Kan, Wu
    Xie, Ruifei
    EXPERIMENTAL LUNG RESEARCH, 2020, 46 (07) : 226 - 233
  • [33] Apoptotic tumor-cell death in response to cell proliferation is influenced by p53 status in resected non-small cell lung cancer
    Tanaka, F
    Takata, T
    Yamada, T
    Yanagihara, K
    Otake, Y
    Miyahara, R
    Nakagawa, T
    Kawano, Y
    Ishikawa, S
    Inui, K
    Wada, H
    LUNG CANCER, 2002, 36 (01) : 27 - 32
  • [34] MiR-550a-3p promotes non-small cell lung cancer cell proliferation and metastasis through down-regulating TIMP2
    Yang, J. -Z.
    Bian, L.
    Hou, J. -G.
    Wang, H. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (13) : 4156 - 4165
  • [35] In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancer
    Jose Antonio Perdomo
    Yoshio Naomoto
    Minoru Haisa
    Toshiyoshi Fujiwara
    Madoka Hamada
    Yasuo Yasuoka
    Noriaki Tanaka
    Journal of Cancer Research and Clinical Oncology, 1998, 124 : 10 - 18
  • [36] In vivo influence of p53 status on proliferation and chemoradiosensitivity in non-small-cell lung cancer
    Perdomo, JA
    Naomoto, Y
    Haisa, M
    Fujiwara, T
    Hamada, M
    Yasuoka, Y
    Tanaka, N
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1998, 124 (01) : 10 - 18
  • [37] SNF5 promotes cell proliferation and immune evasion in non-small cell lung cancer
    Chen, Ying
    Zhao, Meilian
    Shen, Dongliang
    Yi, Qian
    Tang, Liling
    BIOENGINEERED, 2022, 13 (05) : 11530 - 11540
  • [38] Epididymal protein 3A is upregulated and promotes cell proliferation in non-small cell lung cancer
    Li, Guangbin
    Tong, Xing
    Pan, Liangbin
    Huang, Haitao
    Ma, Haitao
    Feng, Yu
    ONCOLOGY LETTERS, 2020, 19 (06) : 4024 - 4030
  • [39] Downregulation of CPT2 promotes proliferation and inhibits apoptosis through p53 pathway in colorectal cancer
    Liu, Fuqiang
    Li, Xiaoqing
    Yan, Han
    Wu, Jiao
    Yang, Yichun
    He, Jin
    Chen, Jun
    Jiang, Zhongxiang
    Wu, Fan
    Jiang, Zheng
    CELLULAR SIGNALLING, 2022, 92
  • [40] tRF-Leu-CAG promotes cell proliferation and cell cycle in non-small cell lung cancer
    Shao, Yang
    Sun, Qiangling
    Liu, Xiaomin
    Wang, Ping
    Wu, Renqi
    Ma, Zhongliang
    CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (05) : 730 - 738